FutForm: Future Formulations Developing Future Pharmaceuticals Through Advanced Analysis and Intersectoral E...
INOVAPOTEK PHARMACEUTICAL RESEARCH AND DEVELOPMENT LDA
participó en un
H2020:
H2020-MSCA-RISE-2015
The estimated cost of getting a new medicine to market is now in excess of $2.6 billion, with an additional $300 million (approx.) typically...
2015-10-28 - 2020-03-31 | Financiado
2015-10-28 - 2020-03-31 | Financiado
SO2S: The Singlet Oxygen Strategy sustainable oxidation procedures for applications in material science...
INOVAPOTEK PHARMACEUTICAL RESEARCH AND DEVELOPMENT LDA
participó en un
FP7:
"The SO2S network seeks to exploit Singlet Oxygen (1O2) as a green and benign oxidant for use in novel synthetic methodologies, crosslinking...
Financiado
Financiado
* No se disponen de datos de la empresa actual.